GLP-1
The medication mechanism may still be appropriate, but vitamin D deficiency, zinc/B6 depletion, copper accumulation, elevated SAH, inflammation, poor sleep, hormonal change, toxic burden or medication interactions may have altered the biochemical environment
Therapeutisches Forschungsprotokoll Dosis: 0,3 0,5 mg (= 1220 Klicks) Dauer: 3 5 Wochen Hufigkeit: Tglich, abendliche Verabreichung Zyklusintervall: 3 4 Wochen Pause vor Wiederholung Ziel / Beschreibung: Hher dosiertes Modell fr Studien zur Stressreaktion und neuroendokrinen Regulation
The terminal metabolites NAP-AGLU and DNAP-AGLU are expected to be much more soluble in water than NAP and its other metabolites
They are not even close to the same thing
10.1371/journal.pone.0107272 183 XiongZ.LairdP